Clinical Trial Update: Seviteronel in Combination With Chemotherapy in Androgen-receptor Positive Metastatic Triple-negative Breast Cancer [Phase 1, Phase 2]

View source ↗

Summary

This update describes a Phase 1/Phase 2 clinical trial evaluating seviteronel in combination with chemotherapy for androgen-receptor–positive metastatic triple-…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Triple-negative Breast Cancer

Drugs mentioned

• Seviteronel (seviteronel)

Snippet

Sponsor: St Vincent's Hospital, Sydney | Conditions: Triple Negative Breast Cancer | Phase 1, Phase 2 | Status: RECRUITING